Get your stacks at https://www.publichealthlaw.best/podcast-stacks now! If you want to learn more about anabolics, SARMs, prohormones visit us at: https://www.publichealthlaw.best/
Q1: What are some of the primary ways anabolic-androgenic steroids (AAS) negatively impact cholesterol levels?
A1: Anabolic-androgenic steroids, particularly oral forms and certain injectable esters, are known to significantly alter lipid profiles. They commonly cause a decrease in high-density lipoprotein cholesterol (HDL-C), often referred to as "good" cholesterol, and an increase in low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol. This unfavorable shift in the HDL-C to LDL-C ratio is a major risk factor for the development of atherosclerosis, the buildup of plaque in the arteries. The degree of these changes can vary depending on the specific steroid used, the dosage, the duration of use, and individual factors.
Q2: How do AAS contribute to hypertension (high blood pressure)?
A2: AAS can lead to an increase in blood pressure through several mechanisms. They can cause fluid retention, leading to an increase in blood volume. Additionally, AAS can increase sympathetic nervous system activity, which can constrict blood vessels. Some steroids may also directly affect the kidneys, leading to increased sodium and water retention. These effects can strain the cardiovascular system and elevate blood pressure, increasing the risk of heart attack, stroke, and other cardiovascular complications.
Q3: What direct effects can AAS have on the heart muscle itself?
A3: AAS can have direct toxic effects on the myocardium (heart muscle), leading to a condition known as anabolic steroid-induced cardiomyopathy. This can manifest as left ventricular hypertrophy (enlargement and thickening of the heart's main pumping chamber), which can impair the heart's ability to relax and pump blood effectively. Over time, this can lead to heart failure, arrhythmias (irregular heartbeats), and an increased risk of sudden cardiac death.
Q4: How do AAS potentially increase the risk of blood clots and stroke?
A4: AAS can increase the production of red blood cells (erythrocytosis), leading to increased blood viscosity (thickness). This thicker blood can slow blood flow and increase the risk of forming blood clots (thrombosis). If these clots travel to the arteries supplying the heart or brain, they can cause a heart attack or stroke, respectively. Some AAS may also directly affect platelet function and coagulation factors, further contributing to this prothrombotic state.
Q5: Can the cardiovascular risks associated with steroid cycles persist even after cessation of use?
A5: While some cardiovascular markers may improve after discontinuing AAS, the long-term effects are not fully understood and some changes may be persistent or irreversible. For example, steroid-induced cardiomyopathy may not fully resolve in all individuals, and the increased risk of atherosclerosis due to prolonged negative lipid profiles may continue to pose a threat. The duration and intensity of past steroid use can influence the extent and persistence of these risks.